Roche’s new AAN 2019 data Event

Roche has hosted a live audio webcast and conference call on Monday, 13 May 2019.


Agenda:
Welcome	Karl Mahler, Head of Investor Relations
Overview of Roche key data at AAN covering new analysis from Ocrevus, satralizumab SakuraSky phase III data, risdiplam one year part I FIREFISH and SUNFISH data and dose selection data for the phase III study in Huntington's Disease	Paulo Fontoura, Global Head Neuroscience and Rare Diseases Clinical Development
Roche Neuroscience and Rare Disease franchise update	Karsten Jung, Therapeutic Area Head Neuroscience and Rare Diseases
Q&A

Please register to access the replay* *Privacy notice

First Name *

Last name *

Corporate Email *

Company Name *

confirm you are a human *

Investors

Downloads

PDF